In addition, B cell maturation antigen (BCMA)-based CAR T cell therapies also have been applied to various B cell-mediated autoimmune diseases including systemic lupus erythematosu, promoting the field of CAR-T cell therapy in autoimmune diseases rapidly evolve (244). The gene discussed is TNFRSF17; the disease is autoimmune disease.